ASEAN and North Asian POC Market by Product (Glucose Monitoring, COVID, HIV, STDs, HAIs, Influenza, Tropical & Respiratory diseases), Technique (Rapid test, Molecular diagnostics), User (Hospital, Home Care) – Forecast to 2026” The ASEAN and North Asian Point of Care/Rapid Diagnostics market size is expected to grow from an estimated USD 2.0 billion in 2021 to USD 3.9 billion by 2026, at a CAGR of 13.0%. The growing demand for accurate and early diagnostic methodologies, modernization and expansion of healthcare infrastructure and significant disease prevalence are the major factors that are expected to drive the growth of the ASEAN and North Asian Point of Care/Rapid Diagnostics market during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219733165
Browse in-depth TOC on “ASEAN and North Asian POC Market”
48 – Tables
02 – Figures
224 – Pages
Key Market Players:
- Roche Diagnostics (Switzerland),
- Siemens Healthineers (Germany),
- Abbott Laboratories (US),
- Danaher Corporation (US),
- Becton, Dickinson and Company (US),
- Sysmex (Japan),
- Cardinal Health (US),
- Quidel (US),
- EKF Diagnostics (UK),
- bioMérieux SA (France),
- Accubiotech (China),
- PTS Diagnostics (US),
- Chembio Diagnostics (US)
- Trinity Biotech (Ireland),
- Johnson and Johnson(US),
- Sekisui Diagnostics (US),
- Nova Biomedical (US),
- Thermo Fisher Scientific (US),
- Ortho Clinical Diagnostics (US)
- Bio-Techne (US).
Driver: Evolving patient preferences and rapid modernization of healthcare services are poised to augment the PoC diagnostics market growth in target countries during next decade
Rapid rates of urbanization and development within the ASEAN and North Asian countries have boosted the overall healthcare environment. Moreover, approximately half of the SEA population lives in urban areas. The ASEAN region is expected to surpass the EU as the world’s second-largest med-tech market (after the US), and most customers will lie beyond the premium segment. Universal insurance schemes are covering more and more people, which will lead to favorable conditions for growth. In addition, ASEAN and North Asian point of care diagnostics are being adopted due to the growing demand for accurate and early diagnostic methodologies.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=219733165
Opportunities: Growth potential offered by emerging markets
Workflow automation and decentralization of diagnostic services offer significant revenue growth opportunities for PoC diagnostic vendors in the region during next decade. Emerging health tech has thrown the spotlight on four areas that set the forces of decentralization in motion. The four areas to watch are Decentralized healthcare at home, Decentralized healthcare at clinics, Insurance providers and HMOs shifting their orientation towards digital solutions, and Major players’ response to decentralization. More than half the labs in developed countries in Asia reported using automation systems, compared to only 28.7% in developing countries. Large labs, defined as those processing over 1,000 samples/day, had a relatively high rate of adoption compared to smaller labs. This suggests that automation of diagnostic workflows is a significant growth opportunity in the ASEAN and North Asian Point of Care/Rapid Diagnostics market.
This research report categorizes the ASEAN and North Asian Point of Care/Rapid Diagnostics market based on product, technology, end user, and country.
Based on the Product:
- Infectious Disease Diagnostics
- Influenza Testing
- Respiratory Infection Testing
- Tropical Disease Testing
- HIV Testing
- STD Testing
- Hepatitis C Testing
- HAI Testing
- COVID Testing
- Other Infectious Disease Testing
Other infectious disease testing products include hepatitis A and B testing products, liver testing products, and Ebola testing products
Other point-of-care products include multi-assay testing, disease-resistant bacteria testing, vitamin assay testing, and other testing products
Based on Technology:
- Lateral Flow Assays
- Immunoassays
- Molecular Diagnostics
- Microfluidics
- Rapid Testing
- Dipsticks
Report Link: ( ASEAN and North Asian POC Market )
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
